Cargando…

Proton pump inhibitors and hypomagnesemia: A meta-analysis of observational studies

BACKGROUND: Previous meta-analyses have suggested that there might be an association between the use of proton pump inhibitors (PPIs) and the development of hypomagnesemia, although the conclusions were no definitive. METHODS: To provide an update on this topic, we performed a meta-analysis of all o...

Descripción completa

Detalles Bibliográficos
Autores principales:	Srinutta, Thawin, Chewcharat, Api, Takkavatakarn, Kullaya, Praditpornsilpa, Kearkiat, Eiam-Ong, Somchai, Jaber, Bertrand L., Susantitaphong, Paweena
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer Health 2019
Materias:	5200
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6946416/ https://www.ncbi.nlm.nih.gov/pubmed/31689852 http://dx.doi.org/10.1097/MD.0000000000017788

Ejemplares similares

Vitamin D supplement on prevention of fall and fracture: A Meta-analysis of Randomized Controlled Trials
por: Thanapluetiwong, Saran, et al.
Publicado: (2020)

Non‐Vitamin K Antagonist Oral Anticoagulants Provide Less Adverse Renal Outcomes Than Warfarin In Non‐Valvular Atrial Fibrillation: A Systematic Review and MetaAnalysis
por: Sitticharoenchai, Patita, et al.
Publicado: (2021)

The impacts of hypoxia-inducible factor stabilizers on laboratory parameters and clinical outcomes in chronic kidney disease patients with renal anemia: a systematic review and meta-analysis
por: Takkavatakarn, Kullaya, et al.
Publicado: (2023)

Factors Associated with the Incidence and Mortality of Coronavirus Disease 2019 (COVID-19) after 126-million Cases: A Meta-analysis
por: Phannajit, Jeerath, et al.
Publicado: (2021)

Association Between Indoxyl Sulfate and Dialysis Initiation and Cardiac Outcomes in Chronic Kidney Disease Patients
por: Takkavatakarn, Kullaya, et al.
Publicado: (2022)

The world prevalence, associated risk factors and mortality of hepatitis C virus infection in hemodialysis patients: a meta-analysis
por: Greeviroj, Primploy, et al.
Publicado: (2022)

The impact of CASR A990G polymorphism in response to cinacalcet treatment in hemodialysis patients with secondary hyperparathyroidism
por: Ngamkam, Jaruwan, et al.
Publicado: (2021)

Treatment of Calciphylaxis in CKD: A Systematic Review and Meta-analysis
por: Udomkarnjananun, Suwasin, et al.
Publicado: (2018)

Protein-Bound Uremic Toxins Lowering Effect of Sevelamer in Pre-Dialysis Chronic Kidney Disease Patients with Hyperphosphatemia: A Randomized Controlled Trial
por: Takkavatakarn, Kullaya, et al.
Publicado: (2021)

Effect of Maintenance Intravenous Iron Treatment on Erythropoietin Dose in Chronic Hemodialysis Patients: A Multicenter Randomized Controlled Trial
por: Susantitaphong, Paweena, et al.
Publicado: (2020)

High sensitivity Troponin-I levels in asymptomatic hemodialysis patients
por: Tarapan, Tanawat, et al.
Publicado: (2019)

Prevalence of Sarcopenia and Its Impact on Cardiovascular Events and Mortality among Dialysis Patients: A Systematic Review and Meta-Analysis
por: Wathanavasin, Wannasit, et al.
Publicado: (2022)

A double-blind, randomized, placebo-controlled trial of combined calcitriol and ergocalciferol versus ergocalciferol alone in chronic kidney disease with proteinuria
por: Susantitaphong, Paweena, et al.
Publicado: (2017)

The effectiveness of cinacalcet: a randomized, open label study in chronic hemodialysis patients with severe secondary hyperparathyroidism
por: Susantitaphong, Paweena, et al.
Publicado: (2019)

Interferon-Inducible Protein 10 and Disease Activity in Systemic Lupus Erythematosus and Lupus Nephritis: A Systematic Review and Meta-Analysis
por: Puapatanakul, Pongpratch, et al.
Publicado: (2019)

Mortality risk factors of COVID-19 infection in kidney transplantation recipients: a systematic review and meta-analysis of cohorts and clinical registries
por: Udomkarnjananun, Suwasin, et al.
Publicado: (2021)

Nonpharmacological Strategies to Prevent Contrast-Induced Acute Kidney Injury
por: Susantitaphong, Paweena, et al.
Publicado: (2014)

A Randomized Controlled Trial of Comparative Efficacy between Sodium Bicarbonate and Heparin as A Locking Solution for Tunneled Central Venous Catheters Among Patients Requiring Maintenance Hemodialysis
por: Wathanavasin, Wannasit, et al.
Publicado: (2021)

Effect of Menaquinone-7 Supplementation on Arterial Stiffness in Chronic Hemodialysis Patients: A Multicenter Randomized Controlled Trial
por: Naiyarakseree, Nuanjanthip, et al.
Publicado: (2023)

Severe hyponatremia as the presenting manifestation of primary empty sella syndrome
por: Takkavatakarn, Kullaya, et al.
Publicado: (2022)

Metabolic alkalosis masked presentation of diabetic ketoacidosis: A case report
por: Wuttiputhanun, Thunyatorn, et al.
Publicado: (2023)

Tacrolimus dose adjustment is not necessary in dose to dose conversion from a twice daily to a prolonged release once daily dose form
por: Tiankanon, Kanitha, et al.
Publicado: (2022)

The magnitude of obesity and metabolic syndrome among diabetic chronic kidney disease population: A nationwide study
por: Kittiskulnam, Piyawan, et al.
Publicado: (2018)

Proton pump inhibitors and hypomagnesemia monitoring
por: Lemon, Thomas I
Publicado: (2013)

Symptomatic hypomagnesemia and proton pump inhibitors
por: Tin, Sim Sai, et al.
Publicado: (2014)

SEA-MAKE score as a tool for predicting major adverse kidney events in critically ill patients with acute kidney injury: results from the SEA-AKI study
por: Sukmark, Theerapon, et al.
Publicado: (2020)

The failure of glomerular filtration rate estimating equations among obese population
por: Kittiskulnam, Piyawan, et al.
Publicado: (2020)

Is hypomagnesemia associated with using proton pump inhibitors?
por: Yi, Joo-Hark, et al.
Publicado: (2016)

Mechanisms of proton pump inhibitor‐induced hypomagnesemia
por: Gommers, Lisanne M. M., et al.
Publicado: (2022)

Alteration of urinary neutrophil gelatinase–associated lipocalin as a predictor of tacrolimus-induced chronic renal allograft fibrosis in tacrolimus dose adjustments following kidney transplantation
por: Chancharoenthana, Wiwat, et al.
Publicado: (2018)

Hypomagnesemia Induced by Long-Term Treatment with Proton-Pump Inhibitors
por: Janett, Simone, et al.
Publicado: (2015)

Proton-pump inhibitor use amongst patients with severe hypomagnesemia
por: Seah, Sherry, et al.
Publicado: (2023)

The beneficial effects of intradialytic parenteral nutrition in hemodialysis patients with protein energy wasting: a prospective randomized controlled trial
por: Kittiskulnam, Piyawan, et al.
Publicado: (2022)

Prevalence and genotype distribution of hepatitis C virus within hemodialysis units in Thailand: role of HCV core antigen in the assessment of viremia
por: Chuaypen, Natthaya, et al.
Publicado: (2022)

Durability of Antibody Response Against the Hepatitis B Virus in Kidney Transplant Recipients: A Proposed Immunization Guideline From a 3-Year Follow-up Clinical Study
por: Chancharoenthana, Wiwat, et al.
Publicado: (2018)

Calcineurin inhibitor therapy in combination with Tripterygium wilfordii polyglycoside tablets for idiopathic membranous nephropathy: A retrospective clinical observation
por: Gao, Ying, et al.
Publicado: (2021)

Proton Pump Inhibitor Prophylaxis After Gastric Bypass Does Not Cause Hypomagnesemia
por: Boerlage, Thomas C. C., et al.
Publicado: (2016)

Prevalence and outcomes of proton pump inhibitor associated hypomagnesemia in chronic kidney disease
por: Hughes, John, et al.
Publicado: (2018)

Proton Pump Inhibitor-Induced Hypomagnesemia: A Rare, Potentially Fatal Complication
por: Pawlukiewicz, Alec J, et al.
Publicado: (2020)

Current Safety of Renal Allograft Biopsy With Indication in Adult Recipients: An Observational Study
por: Tsai, Shang-Feng, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_sf9aqfu9i4skgnbb2co63f7e5h